Molecular analysis and patterns of ALT and hepatitis C virus seroconversion in haemodialysis patients with acute hepatitis

Nephrology

Volumn 13, Issue 3, 2008, Pages 186-192

  Lampe, Elisabeth ^a   Yoshida, Clara Fumiko Tachibana ^a   De Oliveira, Rosane Vieira ^a   Lauer, Georg M ^b   Lewis Ximenez, Lia Laura ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Acute hepatitis; Haemodialysis; Hepatitis C virus; Nosocomial transmission

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY;

ACUTE HEPATITIS; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEROCONVERSION; VIRUS TRANSMISSION;

ADULT; AGED; ALANINE TRANSAMINASE; BRAZIL; CLINICAL ENZYME TESTS; CROSS INFECTION; FEMALE; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; HEMODIALYSIS UNITS, HOSPITAL; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; PHYLOGENY; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; TIME FACTORS;

EID: 40349091232     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2008.00931.x     Document Type: Article

References (25)

1. Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2005. Semin. Dial. 2002 18 : 52 61.
2. Jadoul M. Epidemiology and mechanisms of transmission of the hepatitis C virus in haemodialysis. Nephrol. Dial. Transplant. 2000 15 (Suppl 8 39 41.
3. Fissell RB, Bragg-Gresham JL, Woods JD et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS. Kidney Int. 2004 65 : 2335 42.
4. Di Lallo D, Miceli M, Petrosillo N, Perucci CA, Moscatelli M. Risk factors of hepatitis C virus infection in patient on haemodialysis: A multivariate analysis based on a dialysis register in Central Italy. Eur. J. Epidemiol. 1999 15 : 11 14.
5. Simon N, Courouce M, Lemarrec N, Trepo C, Ducamp S. A twelve-year natural history of hepatitis C virus infection in haemodialyzed patients. Kidney Int. 1994 46 : 504 11.
6. Okuda K, Hayashi H, Kobayashi S, Irie Y. Mode of hepatitis C infection not associated with blood transfusion among chronic haemodialysis patients. J. Hepatol. 1995 23 : 28 31.
7. Gilli P, Moretti M, Soffritti S et al. Non-A, non-B hepatitis and anti-HCV antibodies in dialysis patients. Int. J. Artif Organs. 1990 13 : 737 41.
8. Allander T, Medin C, Jacobson SH, Grillner L, Perssonn MAA. Hepatitis C transmission in a haemodialysis unit: Molecular evidence for spread of virus among patients not sharing equipment. J. Med. Virol. 1994 43 : 415 19.
9. Albuquerque ACC, Coelho MRCD, Lopes EPA, Lemos MF, Moreira RC. Prevalence and risk factors of hepatitis C virus infection in hemodialysis patients from one center in Recife, Brazil. Mem. Inst. Oswaldo Cruz 2005 100 : 467 70.
10. Carneiro MAS, Teles SA, Dias MA et al. Decline of hepatitis C infection in hemodialysis patients in Central Brazil: A ten years of surveillance. Mem. Inst. Oswaldo Cruz 2005 100 : 345 9.
11. Santos AM, Souto FJD. Infection by hepatitis C virus in chronic renal failure patients undergoing hemodialysis in Mato Gorsso state, central Brazil: A cohort study. BMC Public Health 2007 7 : 32.
12. Carneiro MA, Teles SA, Lampe E et al. Molecular and epidemiological study on nosocomial transmission of HCV in hemodialysis patients in Brazil. J. Med. Virol. 2007 79 : 1325 33.
13. Vanderborght BO, Rouzere C, Ginuino CF et al. High prevalence of hepatitis C infection among Brazilian hemodialysis patients in Rio de Janeiro: A one-year follow-up study. Rev. Inst. Med. Trop. Sao Paulo 1995 37 : 75 9.
14. 0 2042. Diário Oficial da União.
15. CDC. Recommendations for preventing transmission of infectious among chronic hemodialysis patients. MMWR 2001 50 : 1 43.
16. de Oliveira JM, Rispeter K, Viazov S et al. Differences in HCV antibody patterns in haemodialysis patients infected with the same virus isolate. J. Med. Virol. 2001 63 : 265 70.
17. Viazov S, Kuzin S, Paladi N. et al. Hepatitis C virus genotypes in different regions of the former Soviet Union (Russia, Belarus, Moldova and Uzbekistan). J. Med. Virol. 1997 53 : 36 40.
18. Kumar S, Tamura K, Nei M MEGA 3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief. Bioinformatics 2004 5 : 150 63.
19. Espinosa M, Martin-Malo A, Alvarez de Lara MA, Soriano S, Aljama P. High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied. Clin. Nephrol. 2000 54 : 151 6.
20. Lopes EP, Gouveia EC, Albuquerque AC et al. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia. J. Clin. Virol., 2006 35 : 298 302.
21. Milotic I, Pavic I, Maleta I, Troselj-Vukic B, Milotic F. Modified range of alanine aminotransferase is insufficient for screening of hepatitis C virus infection in hemodialysis patients. Scand. J. Urol. Nephrol. 2002 36 : 447 9.
22. Stuyver L, Claeys H, Wyseur A et al. Hepatitis C virus in a hemodialysis unit: Molecular evidence for nosocomial transmission. Kidney Int. 1996 49 : 889 95.
23. Seme K, Poljak M, Zuzec-Resek S, Debeljak M, Dovc P, Koren S. Molecular evidence for nosocomial spread of two different hepatitis C virus strains in one hemodialysis unit. Nephron 1997 77 : 273 8.
24. Saxena AK, Panhotra BR. The vulnerability of middle-aged and elderly patients to hepatitis C virus infection in a high-prevalence hospital-based hemodialysis setting. J. Am. Geriatr. Soc. 2004 52 : 242 6.
25. Saxena AK, Panhotra BR. The susceptibility of patients with type-2 diabetes to hepatitis C virus infection during long-term haemodialysis. Swiss Med. Wkly. 2003 133 : 611 18.